FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

32570211000036100: Substance foundation reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Nov 2009. Module: SNOMED Clinical Terms Australian extension

Descriptions:

Id Description Lang Type Status Case? Module
108642371000036113 Substance foundation reference set (foundation metadata concept) en Fully specified name Active Case insensitive SNOMED Clinical Terms Australian extension
108642381000036110 Substance foundation reference set en Synonym Active Case insensitive SNOMED Clinical Terms Australian extension
4351461000168113 <p>Supports the recording of substances in Australian e-health implementations.</p><p>This reference set can be used:<ul><li>Within implementations where use-case specific reference sets for substances are yet to be developed.</li><li>As the basis for developing further use-case specific reference sets for substances, through a process of constraint.</li><li>As a benchmark against which use-case specific reference sets that have been developed by the SNOMED CT-AU user community can be tested to assure that they are logical constraints of content relating to substances.</li></ul></p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive SNOMED Clinical Terms Australian extension


27331 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance foundation reference set Developed by Australian Digital Health Agency true Inferred relationship Some 926724414
Substance foundation reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1675684939
Substance foundation reference set Is a Foundation reference sets true Inferred relationship Some
Substance foundation reference set Is a Attribute value type false Inferred relationship Some
Substance foundation reference set Is a Simple type reference set true Inferred relationship Some

Members
Interleukin receptor antagonist
Interleukin-3 receptor alpha antagonist
Interleukin-4 receptor alpha antagonist
Isocitrate dehydrogenase-1 inhibitor
Isocitrate dehydrogenase-2 inhibitor
Isomerase
Kallikrein inhibitor
Kinase
Leukotriene receptor antagonist
Ligase
Lipase inhibitor
Lyase
Lymphocyte function-associated antigen 1 antagonist
Macrolide antibacterial
Mast cell stabiliser
Melanocortin receptor agonist
Melatonin agonist
Mesenchymal epithelial transition inhibitor
Methyltransferase inhibitor
Methyltransferase
Microsomal triglyceride transfer protein inhibitor
Microtubule inhibitor
Mitogen-activated protein kinase kinase 1 inhibitor
Mitogen-activated protein kinase kinase 2 inhibitor
Mitogen-activated protein kinase kinase inhibitor
Mitotic inhibitor
Molecular messenger
Substance with monoamine oxidase A inhibitor mechanism of action
Monoamine oxidase B inhibitor
Monoamine oxidase inhibitor
Morphinan opioid
Muscarinic receptor agonist
Muscarinic receptor antagonist
Mutase
Neprilysin inhibitor
Nerve growth factor agonist
Neuraminidase inhibitor
Neurokinin 1 receptor antagonist
Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor
Nicotinic receptor agonist
Substance with nicotinic receptor antagonist mechanism of action
Non-chaperonin molecular chaperone ATPase inhibitor
Non-specific protein-tyrosine kinase inhibitor
Noradrenaline reuptake inhibitor and serotonin reuptake inhibitor
Noradrenaline reuptake inhibitor
Noradrenaline uptake inhibitor
Nucleotidyltransferase inhibitor
Opioid receptor agonist
Opioid receptor antagonist
Opioid receptor partial agonist
Opioid receptor partial antagonist
Orexin receptor antagonist
Organophosphorus acetylcholinesterase inhibitor
Orotate phosphoribosyltransferase inhibitor
Oxazolidinone antibacterial
Oxidase
Oxidoreductase inhibitor
Oxidoreductase
Oxygenase
Substance with oxyquinoline structure
Pantothenate kinase inhibitor
Penicillin antibacterial
Substance with pentosyltransferase inhibitor mechanism of action
Peptide hormone receptor antagonist
Peptide hydrolase inhibitor
Peptide hydrolase
Peroxidase
Peroxisome proliferator-activated alpha receptor agonist
Peroxisome proliferator-activated gamma receptor agonist
Peroxisome proliferator-activated receptor agonist
Substance with phenol structure
Phosphodiesterase 3 inhibitor
Phosphodiesterase 4 inhibitor
Phosphodiesterase 5 inhibitor
Phosphodiesterase inhibitor
Phosphodiesterase
Phosphoinositide 3 kinase inhibitor
Phosphoribosylglycinamide formyltransferase inhibitor
Substance with phosphoric monoester hydrolase mechanism of action (substance)
Phosphorylase
Phosphotransferase inhibitor
Plasmin inhibitor
Plasminogen activator inhibitor
Plasminogen activator
Platelet aggregation inhibitor
Polyadenosine 5'-diphosphoribose polymerase inhibitor
Polybrominated diphenyl ether
Potassium channel activator
Potassium channel blocker
Progesterone receptor agonist
Substance with progesterone receptor antagonist mechanism of action
Programmed cell death protein 1 inhibitor
Prolyl oligopeptidase inhibitor
PCSK9 inhibitor
Prostacyclin receptor agonist
Cyclooxygenase inhibitor
Cyclooxygenase-1 inhibitor
Cyclooxygenase-2 inhibitor
Cyclooxygenase-3 inhibitor
Protease inhibitor
Proteasome inhibitor

Start Previous Page 245 of 274 Next End


Reference Sets

Reference set descriptor

Back to Start